Tyzeka
Tyzeka
Tyzeka (pronounced: tie-ZEH-ka), also known as telbivudine, is an antiviral drug used in the treatment of hepatitis B infection. It is marketed by Novartis under the trade name Tyzeka, and is also available in some countries under the trade name Sebivo.
Pronunciation
Tyzeka is pronounced as tie-ZEH-ka.
Etymology
The name Tyzeka does not have a known etymology. It is a brand name created by the pharmaceutical company Novartis.
Usage
Tyzeka is used to treat chronic hepatitis B in adults. It works by slowing the growth of the virus. It is not a cure for hepatitis B and does not prevent the spread of the virus to others.
Related Terms
- Antiviral drug: A type of medication used specifically for treating viral infections.
- Hepatitis B: A serious liver infection caused by the hepatitis B virus.
- Novartis: A Swiss multinational pharmaceutical company based in Basel, Switzerland.
Side Effects
Common side effects of Tyzeka include fatigue, headache, dizziness, and nausea. Serious side effects may include peripheral neuropathy and an increase in serum creatinine.
Precautions
Before taking Tyzeka, tell your doctor if you have any other medical conditions, especially kidney disease or a history of nerve problems. Also inform your doctor if you are pregnant or plan to become pregnant, as Tyzeka could harm the unborn baby.
Interactions
Tyzeka can interact with other medications, vitamins, or herbs you may be taking. An interaction is when a substance changes the way a drug works.
See Also
External links
- Medical encyclopedia article on Tyzeka
- Wikipedia's article - Tyzeka
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski